Human Reproduction, Vol. 18, No. 7, 1422-1427,
July 2003
© 2003 European Society of Human Reproduction and Embryology
Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study
1 Research Institute for Endocrinology, Reproduction and Metabolism, Department of Obstetrics and Gynaecology, Division of Reproductive Endocrinology and Fertility and the IVF Centre and 2 Department of Clinical Epidemiology and Biostatistics Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
3 To whom correspondence should be addressed at: Vrije Universiteit Medical Centre, IVF Centre P.O.Box 7057, 1007 MB Amsterdam, The Netherlands. e-mail: j.kwee{at}vumc.nl
BACKGROUND: This study was designed to compare endocrine tests [clomiphene citrate challenge test (CCT), exogenous FSH ovarian reserve test (EFORT) and basal FSH, basal estradiol (E2) and basal inhibin B as an integral part of all CCT and EFORT], with respect to their ability to estimate the stimulable cohort of follicles in the ovaries (ovarian capacity) and to analyse which test or combination of tests would give the best prediction of ovarian capacity. METHODS: A total of 110 regularly menstruating patients, aged 18–39 years, participated in this prospective study, randomized by a computer-designed 4-block system study into two groups. Fifty-six patients underwent a CCT, and 54 patients underwent an EFORT. In all patients, the test was followed by an IVF treatment. The result of ovarian hyperstimulation during IVF treatment, expressed by the total number of follicles, was used as gold standard. RESULTS: Univariate linear regression analysis showed that the best correlation with the number of follicles after ovarian hyperstimulation (Y) is found by the inhibin B increment (InhB incr.) in the EFORT (Y = 3.957 + 0.081 x InhB incr. (95% CI 0.061–0.101); r = 0.751; P < 0.001). Multiple linear regression analysis showed a significant contributing value of the variables basal FSH, E2 increment of the EFORT and inhibin B increment to the basic model with the variable age. The best prediction of ovarian capacity (Y) was seen when E2 increment and inhibin B increment were used simultaneously in a stepforward multiple regression prediction model [Y = 2.659 + 0.052 x InhB incr. (0.026–0.078) + 0.027 x E2 incr. (95% CI 0.012–0.054); r = 0.796; P < 0.001]. The CCT could not be used in a prediction model. CONCLUSIONS: The EFORT is the endocrine test which gives the best prediction of ovarian capacity.
Key words: basal FSH/basal inhibin B/CCT/EFORT/ovarian capacity
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C.H. de Koning, J. McDonnell, A.P.N. Themmen, F.H. de Jong, R. Homburg, and C.B. Lambalk The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls Hum. Reprod., June 1, 2008; 23(6): 1416 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.L. Haadsma, A. Bukman, H. Groen, E.M.A. Roeloffzen, E.R. Groenewoud, M.J. Heineman, and A. Hoek The number of small antral follicles (2-6 mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population Hum. Reprod., July 1, 2007; 22(7): 1925 - 1931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, and C.B. Lambalk A systematic review of tests predicting ovarian reserve and IVF outcome Hum. Reprod. Update, November 1, 2006; 12(6): 685 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.H. de Koning, T. Benjamins, P. Harms, R. Homburg, J.M. van Montfrans, J. Gromoll, M. Simoni, and C.B. Lambalk The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles Hum. Reprod., February 1, 2006; 21(2): 443 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Eldar-Geva, A. Ben-Chetrit, I. M. Spitz, R. Rabinowitz, E. Markowitz, T. Mimoni, M. Gal, E. Zylber-Haran, and E. J. Margalioth Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome Hum. Reprod., November 1, 2005; 20(11): 3178 - 3183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Y. Ng, C. C. W. Chan, O. S. Tang, and P. C. Ho Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment Hum. Reprod., June 1, 2005; 20(6): 1647 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
ESHRE Capri Workshop Group Fertility and ageing Hum. Reprod. Update, May 1, 2005; 11(3): 261 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lutchman Singh, M. Davies, and R. Chatterjee Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.J. Hendriks, F.J.M. Broekmans, L.F.J.M.M. Bancsi, F.H. de Jong, C.W.N. Looman, and E.R. te Velde Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve Hum. Reprod., January 1, 2005; 20(1): 163 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lass Assessment of ovarian reserve: Is there still a role for ovarian biopsy in the light of new data? Hum. Reprod., March 1, 2004; 19(3): 467 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. I. Sharara and R. T. Scott Assessment of ovarian reserve. Is there still a role for ovarian biopsy?: First do no harm! Hum. Reprod., March 1, 2004; 19(3): 470 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kwee, R. Schats, J. McDonnell, C.B. Lambalk, and J. Schoemaker Intercycle variability of ovarian reserve tests: results of a prospective randomized study Hum. Reprod., March 1, 2004; 19(3): 590 - 595. [Abstract] [Full Text] [PDF]
|
|